Vital Therapies Inc (VTL)-製薬・医療分野:企業M&A・提携分析

◆英語タイトル:Vital Therapies Inc (VTL) - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA8013511
◆発行会社(調査会社):GlobalData
◆発行日:2017年11月28日
◆ページ数:41
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single UserUSD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Vital Therapies Inc (Vital Therapies) is a biotherapeutic company that develops cell-based therapy treatment for acute forms of liver failure. The company offers ELAD system, a human hepatic cell-based liver support system designed to liver function in patients with life-threatening, acute liver failure by processing toxins and synthesizing proteins. Vital Therapies’s ELAD System contains immortal human liver-derived cells or VTL C3A cells that performs biochemical functions characteristic of human hepatocytes in in-vitro assays. Vital Therapies also provides programs for severe acute alcoholic hepatitis and alcohol induced liver decompensation, surgery-induced liver failure, fulminant liver failure, and chronic liver failure. It also conducts clinical trials. Vital Therapies is headquartered in San Diego, California, the US.

Vital Therapies Inc (VTL) – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vital Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2011 to YTD 2017 8
Vital Therapies Inc, Medical Devices Deals, 2011 to YTD 2017 9
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deal Details 11
Venture Financing 11
Vital Therapies Raises US$32 Million In Venture Financing 11
Vital Therapies Raises US$12 Million In Venture Financing 12
Vital Therapies Increases Size Of Financing To US$100 Million 13
Vital Therapies Secures USD4.35 Million in Venture Funding 15
Equity Offering 16
Vital Therapies Raises USD40.3 Million in Public Offering of Shares 16
Vital Therapies Raises USD34.5 Million in Public Offering of Shares 18
Vital Therapies Completes Partial Exercise of Underwriter’s Over Allotment Option of Public Offering of Shares for USD36 Million 20
Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$62.1 Million 22
Vital Therapies Inc – Key Competitors 24
Vital Therapies Inc – Key Employees 25
Vital Therapies Inc – Locations And Subsidiaries 26
Head Office 26
Other Locations & Subsidiaries 26
Recent Developments 27
Financial Announcements 27
Oct 25, 2017: Vital Therapies Announces Third Quarter 2017 Financial Results 27
Aug 03, 2017: Vital Therapies Announces Second Quarter 2017 Financial Results 29
May 09, 2017: Vital Therapies Announces First Quarter 2017 Financial Results 30
Mar 07, 2017: Vital Therapies Announces Fourth Quarter and Full Year 2016 Financial Results 31
Nov 03, 2016: Vital Therapies Announces Third Quarter Financial Results 32
Aug 02, 2016: Vital Therapies Announces Second Quarter Financial Results 33
May 09, 2016: Vital Therapies Announces First Quarter Financial Results 34
Mar 08, 2016: Vital Therapies Announces Fourth Quarter and Full Year 2015 Financial Results and Provides Corporate Update 35
Corporate Communications 37
Sep 06, 2017: Vital Therapies Appoints Former Receptos President and CEO Faheem Hasnain as Chairman of the Board of Directors 37
Aug 15, 2016: Vital Therapies Announces Appointment of Former Receptos President and CEO Faheem Hasnain to Its Board of Directors 38
Clinical Trials 39
Jun 05, 2017: Vital Therapies Announces Characteristics of Early Subjects in VTL-308 Pivotal Study of ELAD System in Severe Alcoholic Hepatitis 39
May 23, 2016: Vital Therapies Enrolls First Subject in VTL-308 40
Appendix 41
Methodology 41
About GlobalData 41
Contact Us 41
Disclaimer 41

List of Tables
Vital Therapies Inc, Pharmaceuticals & Healthcare, Key Facts, 2016 2
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 5
Vital Therapies Inc, Pharmaceuticals & Healthcare Deals By Type, 2011 to YTD 2017 6
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals By Region, 2011 to YTD 2017 7
Vital Therapies Inc, Deals By Therapy Area, 2011 to YTD 2017 8
Vital Therapies Inc, Medical Devices Deals, 2011 to YTD 2017 9
Vital Therapies Inc, Pharmaceuticals & Healthcare, Deals Summary, 2011 to YTD 2017 10
Vital Therapies Raises US$32 Million In Venture Financing 11
Vital Therapies Raises US$12 Million In Venture Financing 12
Vital Therapies Increases Size Of Financing To US$100 Million 13
Vital Therapies Secures USD4.35 Million in Venture Funding 15
Vital Therapies Raises USD40.3 Million in Public Offering of Shares 16
Vital Therapies Raises USD34.5 Million in Public Offering of Shares 18
Vital Therapies Completes Partial Exercise of Underwriter's Over Allotment Option of Public Offering of Shares for USD36 Million 20
Vital Therapies Completes Underwriters Exercise Of Full Over-Allotment Option Of IPO For US$62.1 Million 22
Vital Therapies Inc, Key Competitors 24
Vital Therapies Inc, Key Employees 25
Vital Therapies Inc, Subsidiaries 26

★海外企業調査レポート[Vital Therapies Inc (VTL)-製薬・医療分野:企業M&A・提携分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Koch Industries Inc:企業の戦略的SWOT分析
    Koch Industries Inc - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and se …
  • Enel Generacion Peru SAA (EDEGELC1):企業の財務・戦略的SWOT分析
    Summary Enel Generacion Peru SAA (Enel Generacion) a subsidiary of Enel Americas SA, is a power generation company. It offers transmission and distribution of electricity. The company generates electricity through thermal and hydroelectric sources. It also carries out hydroelectric plant generation …
  • The Medicines Company (MDCO)-医療機器分野:企業M&A・提携分析
    Summary The Medicines Company (TMC) is a biopharmaceutical company, which provides medical solutions for improving health conditions in patients under critical care. The company’s product portfolio comprises marketed products, namely, Angiomax (bivalirudin), Orbactiv (oritavancin), Minocin (minocycl …
  • DexCom Inc (DXCM):企業の製品パイプライン分析
    Summary Dexcom Inc (Dexcom) is a medical device company that designs, develops and commercializes continuous glucose monitoring (CGM) systems. The company’s major products include integrated CGM systems for adults and pediatric use, Dexcom G5 mobile CGM system, Dexcom G4 PLATINUM CGM system, associa …
  • Southern Petrochemical Industries Corp Ltd (SPIC):企業の財務・戦略的SWOT分析
    Summary Southern Petrochemical Industries Corp Ltd (SPIC) is a chemical company that manufactures fertilizers for agriculture. The company offers products such as chemical fertilizer, organic and water soluble fertilizers, plant growth regulators, micro nutrients, and industrial products. Its chemic …
  • Globavir Biosciences Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Globavir Biosciences Inc (Globavir) is a biotechnology company that develop combination of drug therapies and diagnostic tests in the therapeutic areas of infection and immune-oncology. The company develops Globavir’s Drug Discovery Platform (GDDP), which generates small molecule candidates …
  • Federal-Mogul Holdings LLC:企業の戦略的SWOT分析
    Federal-Mogul Holdings LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products …
  • VAALCO Energy Inc (EGY):企業の財務・戦略的SWOT分析
    VAALCO Energy Inc (EGY) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses a …
  • Therabron Therapeutics Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Therabron Therapeutics Inc (Therabron), formerly Clarassance Inc is a clinical-stage biopharmaceutical company that develops drugs based on secretoglobin family of proteins. The company’s lead biopharmaceutical candidate includes CG100, CG201, CG367, CG459 and CG1011. Its CC10 protein candid …
  • EarLens Corp:医療機器:M&Aディール及び事業提携情報
    Summary EarLens Corp (EarLens) is engaged in designing and manufacturing of hearing aid products for hearing impaired patients. Its lead product Earlens Hearing Aid is a hearing device that utilizes light to transmit sound. The device automatically adjusts to noisy environments and delivers the broa …
  • CSL Ltd (CSL):製薬・医療:M&Aディール及び事業提携情報
    Summary CSL Ltd (CSL) discovers, develops, manufactures, markets and distributes biopharmaceuticals and related products. Its portfolio encompasses plasma-derived products for the treatment of bleeding disorders such as hemophilia and von Willebrand disease, hereditary angioedema, primary and second …
  • Guthy-Renker LLC:企業の戦略的SWOT分析
    Guthy-Renker LLC - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and servi …
  • Goldman Sachs Private Wealth Management:企業の戦略・SWOT・財務情報
    Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report Summary Goldman Sachs Private Wealth Management - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT a …
  • Cyberhawk Innovations Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary Cyberhawk Innovations Ltd (Cyberhawk), formerly Castlelaw (No.740) Ltd is an engineering company that provides aerial inspection and land surveying services. The company conducts close visual and thermal inspections of industrial assets both on- and offshore. It offers industrial inspection …
  • Aptose Biosciences Inc (APTO):企業の財務・戦略的SWOT分析
    Aptose Biosciences Inc (APTO) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Radboud University Nijmegen Medical Centre-製薬・医療分野:企業M&A・提携分析
    Summary Radboud University Nijmegen Medical Centre (Radboud UMC), a subsidiary of Radboud University is a university medical center that offers patient care, research, and scientific training services. The centre’s patient care services include basic care, tertiary care, top referral care, and trans …
  • Tanzania Electric Supply Co Ltd:企業の戦略的SWOT分析
    Tanzania Electric Supply Co Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major pro …
  • Viamet Pharmaceuticals Inc-製薬・医療分野:企業M&A・提携分析
    Summary Viamet Pharmaceuticals Inc (Viamet), a subsidiary of Viamet Pharmaceuticals Holdings LLC is a provider of metalloenzyme inhibitors and antifungal agents. The company offers novel agents to treat both chronic and life threatening fungal infections. Its product pipeline includes clinical-stage …
  • Mercury NZ:企業の戦略・SWOT・財務情報
    Mercury NZ - Strategy, SWOT and Corporate Finance Report Summary Mercury NZ - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actio …
  • Diffusion Pharmaceuticals Inc (DFFN)-製薬・医療分野:企業M&A・提携分析
    Summary Diffusion Pharmaceuticals Inc (Diffusion), formerly Diffusion Pharmaceuticals LLC is a drug development company that develops standard-of-care therapies. The company offers new and small-molecule drugs for regulating the movement of oxygen into tissue. It provides therapeutic for life-threat …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆